Keywords
Regulación sanitaria
Nanotecnología
Medical Devices Biomedical Technology
Health Regulation
Nanotechnology
Dispositivos médicos
How to Cite
Abstract
Innovation in health technologies poses significant regulatory challenges, particularly regarding the increasing use of nanomaterials in medical devices. This editorial outlines the main phases in development and evaluation, emphasizing the importance of international standards, post-market surveillance, and institutional collaboration. In countries like Colombia, regulatory gaps in nanotechnology remain, highlighting the need to update frameworks to ensure product safety and efficacy.
References
Organización Mundial de la Salud. Consejo Ejecutivo 118ª Reunión. Punto 5.5. Tecnologías Sanitarias esenciales. Informe de Secretaría. Mayo 25, 2006. https://apps.who.int/gb/ebwha/pdf_files/EB118/B118_15-sp.pdf
Organización Mundial de la Salud. 60ª Asamblea Mundial de la Salud. Punto 12.19 del orden del día. WHA60.29. Tecnologías Sanitarias. Mayo 23, 2007. https://apps.who.int/gb/ebwha/pdf_files/WHA60/A60_R29-sp.pdf
Adnan ASHFAQ. Understanding the 5 Phases of Medical Device Development. Enero 20,2023. https://www.greenlight.guru/blog/5-phases-of-medical-device-development
U. S. Food and Drug Administration (2013). Use of International Standard ISO 10993-1, “Biological evaluation of medical devices – Part 1: Evaluation and testing within a risk management process”. https://www.fda.gov/downloads/MedicalDevices/DeviceRegulationandGuidance/GuidanceDocuments/ucm348890.pdf
Grupo ETC. ¿Qué pasa con la nanotecnología? Regulación y geopolítica. Comuniqué no. 105 Publicado en Ottawa, Canadá, diciembre de 2010. http://www.etcgroup.org/sites/www.etcgroup.org/files/Nanogeopoli%CC%81tica_4webSep2011.pdf
6. Etheridge ML, Campbell SA, Erdman AG, Haynes CL, Wolf SM, McCullough J. The big picture on nanomedicine: the state of investigational and approved nanomedicine products. Nanomedicine. 2013 Jan;9(1):1-14. https://doi.org/10.1016/j.nano.2012.05.013
Christine Vauthier. Issues related with the analysis of nanomaterials. Handbook of nanomaterials in analytical chemistry, 2020, ff10.1016/B-978-0-12-816699-4.00019-0ff. ffhal-02984050f https://doi.org/10.1016/B978-0-12-816699-4.00019-0
Dutz S. et Herg R. Magnetic particle hyperthermia--a promising tumour therapy? Nanotechnology. 2014 Nov 14;25(45):452001. doi: 10.1088/0957-4484/25/45/452001 https://doi.org/10.1088/0957-4484/25/45/452001SCENIHR
SCENIHR (Scientific Committee on Emerging and Newly Identified Health Risks), Final Opinion on the Guidance on the Determination of Potential Health Effects of Nanomaterials Used in Medical Devices, January 2015. https://ec.europa.eu/health/scientific_committees/emerging/docs/scenihr_o_045.pdf
López-de la Mora DA. Identificación de posibles riesgos toxicológicos y sus regulaciones sanitarias del uso de nanomateriales en productos de consumo humano en México. Revista Médica Volumen 10, número 3; febrero - abril 2019.